Combining secukinumab and fingolimod to successfully treat ankylosing spondylitis and multiple sclerosis - A novel approach.

Combining secukinumab and fingolimod to successfully treat ankylosing spondylitis and multiple sclerosis - A novel approach. Biologicals. 2019 Jun 13;: Authors: Nisar MK PMID: 31204079 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31204079?dopt=Abstract

Source: Biologicals : Journal of the International Association of Biological Standardization - June 12, 2019 Category: Biotechnology Authors: Nisar MK Tags: Biologicals Source Type: research

More News: Ankylosing Spondylitis | Biotechnology | Gilenya | Multiple Sclerosis | Science